Ufp Technologies (UFPT) Cash from Operations Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Ufp Technologies | 1.69 Bn | 1.67 Bn | 44.36 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.79% |
| Dec 31, 2025 | 15.20% |
| Sep 30, 2025 | 43.03% |
| Jun 30, 2025 | 33.41% |
| Mar 31, 2025 | 23.84% |
| Dec 31, 2024 | 22.53% |
| Sep 30, 2024 | 14.58% |
| Jun 30, 2024 | 6.06% |
| Mar 31, 2024 | 24.04% |
| Dec 31, 2023 | 10.32% |
| Sep 30, 2023 | 24.20% |
| Jun 30, 2023 | -1.22% |
| Mar 31, 2023 | 23.43% |
| Dec 31, 2022 | 32.03% |
| Sep 30, 2022 | -15.12% |
| Jun 30, 2022 | -3.43% |
| Mar 31, 2022 | -22.67% |
| Dec 31, 2021 | -27.32% |
| Sep 30, 2021 | -5.29% |
| Jun 30, 2021 | 11.47% |
| Mar 31, 2021 | 27.18% |
| Dec 31, 2020 | 20.46% |
| Sep 30, 2020 | 11.01% |
| Jun 30, 2020 | -2.61% |
| Mar 31, 2020 | 43.61% |
| Dec 31, 2019 | 15.65% |
| Sep 30, 2019 | 15.35% |
| Jun 30, 2019 | 24.25% |
| Mar 31, 2019 | 41.17% |
| Dec 31, 2018 | 11.22% |
| Sep 30, 2018 | -1.15% |
| Jun 30, 2018 | 13.74% |
| Mar 31, 2018 | -80.80% |
| Dec 31, 2017 | -3.54% |
| Sep 30, 2017 | 0.67% |
| Jun 30, 2017 | -2.27% |
| Mar 31, 2017 | 20.10% |
| Dec 31, 2016 | 7.59% |
| Sep 30, 2016 | 3.78% |
| Jun 30, 2016 | -4.73% |
| Mar 31, 2016 | -43.16% |
| Dec 31, 2015 | 3.35% |
| Sep 30, 2015 | -2.43% |